QI
GTHX

QS Investors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

QS Investors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$360K Hold
16,400
– – ﹤0.01% 868
2021
Q1 		$395K Hold
16,400
– – ﹤0.01% 886
2020
Q4 		$295K Buy
+16,400
New +$245K ﹤0.01% 1000

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

QS Investors's GTHX Position: Q2 2021 in Review

QS Investors held its G1 Therapeutics, Inc. Common Stock (GTHX) position steady in Q2 2021 at 16,400 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #868.

QS Investors first reported a position in GTHX in Q4 2020 and has held it in 3 quarters since. The position peaked at $395K in Q1 2021. 114 funds tracked by Wall St. Rank hold GTHX as of Q2 2021.

  • QS Investors held 16,400 shares of G1 Therapeutics, Inc. Common Stock worth $360K as of Q2 2021.
  • QS Investors left its G1 Therapeutics, Inc. Common Stock share count unchanged in Q2 2021.
  • G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #868 holding.
  • QS Investors first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2020 and has held it in 3 quarters since.
  • QS Investors's G1 Therapeutics, Inc. Common Stock position peaked at $395K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.